NRT and lung cancer?
This article was originally published in The Tan Sheet
Executive Summary
It is "a possibility that exposure to nicotine, by smoking or through nicotine supplements, might negatively impact the response to chemotherapeutic agents," Piyali Dasgupta, H. Lee Moffitt Cancer Research Center, Tampa, FL, et al., report at the American Association for Cancer Research annual meeting in Washington, D.C. April 2. Although nicotine is not a carcinogen, "it can induce cell proliferation" and suppress the killing of cancer cells induced by certain agents, the authors note. Their study finds that administering nicotine (1 µm) inhibited treatments for non-small cell lung cancer, such as gemcitabine, cisplatin and taxol...